Many clinical studies have shown that having a high triglyceride blood level — a condition called hypertriglyceridemia — is also associated with a substantially elevated cardiovascular risk. While ...

Shanghai Argo Pharmaceutical (Argo Biopharma) is a clinical stage biotech company that develops a new generation of siRNA drugs to provide better treatment for patients. The company develops and ...

Severe hypertriglyceridemia is a major risk factor for acute pancreatitis. In exceptional cases, it is caused by plasma components inhibiting lipoprotein lipase activity. This phenomenon is ...

A GROUNDBREAKING phase 2b randomized clinical trial has demonstrated that plozasiran, an investigational APOC3-targeted siRNA therapeutic, significantly reduces triglyceride levels in patients with ...

Olezarsen, a new investigational drug that blocks production of apolipoprotein C-III (apoC3), may cut triglyceride levels nearly in half, as well as lower apoC3 and apolipoprotein B (apoB) levels in ...